nodes	percent_of_prediction	percent_of_DWPC	metapath
Verapamil—ABCC10—Cyclosporine—psoriasis	0.0456	0.0604	CbGbCtD
Verapamil—ABCC3—Cyclosporine—psoriasis	0.0287	0.038	CbGbCtD
Verapamil—ABCB11—Cyclosporine—psoriasis	0.0248	0.0328	CbGbCtD
Verapamil—ABCC10—Methotrexate—psoriasis	0.0241	0.032	CbGbCtD
Verapamil—CYP2C8—Tazarotene—psoriasis	0.0224	0.0296	CbGbCtD
Verapamil—CYP3A5—Beclomethasone—psoriasis	0.0216	0.0287	CbGbCtD
Verapamil—CYP1A2—Clobetasol propionate—psoriasis	0.0212	0.0281	CbGbCtD
Verapamil—SLCO1B1—Mycophenolate mofetil—psoriasis	0.0196	0.0259	CbGbCtD
Verapamil—ABCC1—Cyclosporine—psoriasis	0.0176	0.0233	CbGbCtD
Verapamil—SLCO1A2—Prednisolone—psoriasis	0.0176	0.0233	CbGbCtD
Verapamil—ABCC2—Mycophenolate mofetil—psoriasis	0.0172	0.0228	CbGbCtD
Verapamil—SLCO1A2—Hydrocortisone—psoriasis	0.0166	0.022	CbGbCtD
Verapamil—SLCO1A2—Prednisone—psoriasis	0.0166	0.022	CbGbCtD
Verapamil—ABCB11—Dexamethasone—psoriasis	0.0163	0.0216	CbGbCtD
Verapamil—SLCO1A2—Cyclosporine—psoriasis	0.0157	0.0208	CbGbCtD
Verapamil—ABCG2—Mycophenolate mofetil—psoriasis	0.0155	0.0206	CbGbCtD
Verapamil—ABCC3—Methotrexate—psoriasis	0.0152	0.0201	CbGbCtD
Verapamil—SLCO1B1—Cyclosporine—psoriasis	0.0148	0.0196	CbGbCtD
Verapamil—ABCC2—Cyclosporine—psoriasis	0.013	0.0173	CbGbCtD
Verapamil—CYP2B6—Cholecalciferol—psoriasis	0.0126	0.0167	CbGbCtD
Verapamil—ABCG2—Hydrocortisone—psoriasis	0.0125	0.0165	CbGbCtD
Verapamil—ABCG2—Cyclosporine—psoriasis	0.0118	0.0156	CbGbCtD
Verapamil—ABCC4—Methotrexate—psoriasis	0.0116	0.0154	CbGbCtD
Verapamil—CYP1A2—Methoxsalen—psoriasis	0.0112	0.0148	CbGbCtD
Verapamil—SLCO1A2—Dexamethasone—psoriasis	0.0104	0.0137	CbGbCtD
Verapamil—CYP2D6—Hydroxyurea—psoriasis	0.0101	0.0133	CbGbCtD
Verapamil—CYP2C8—Cholecalciferol—psoriasis	0.00955	0.0126	CbGbCtD
Verapamil—ABCC1—Methotrexate—psoriasis	0.00932	0.0123	CbGbCtD
Verapamil—CYP3A7-CYP3A51P—Hydrocortisone—psoriasis	0.00921	0.0122	CbGbCtD
Verapamil—CYP3A7—Hydrocortisone—psoriasis	0.00921	0.0122	CbGbCtD
Verapamil—CACNA1S—pes—psoriasis	0.00872	0.62	CbGeAlD
Verapamil—CYP3A7-CYP3A51P—Cyclosporine—psoriasis	0.0087	0.0115	CbGbCtD
Verapamil—CYP3A7—Cyclosporine—psoriasis	0.0087	0.0115	CbGbCtD
Verapamil—CYP3A5—Mycophenolate mofetil—psoriasis	0.00861	0.0114	CbGbCtD
Verapamil—ABCC2—Dexamethasone—psoriasis	0.00858	0.0114	CbGbCtD
Verapamil—SLCO1A2—Methotrexate—psoriasis	0.00832	0.011	CbGbCtD
Verapamil—CYP2C8—Mycophenolate mofetil—psoriasis	0.00828	0.011	CbGbCtD
Verapamil—CYP2C19—Cholecalciferol—psoriasis	0.00801	0.0106	CbGbCtD
Verapamil—SLCO1B1—Methotrexate—psoriasis	0.00785	0.0104	CbGbCtD
Verapamil—ABCG2—Dexamethasone—psoriasis	0.00776	0.0103	CbGbCtD
Verapamil—CYP3A4—Calcitriol—psoriasis	0.00752	0.00996	CbGbCtD
Verapamil—CYP3A5—Hydrocortisone—psoriasis	0.00691	0.00915	CbGbCtD
Verapamil—ABCC2—Methotrexate—psoriasis	0.0069	0.00913	CbGbCtD
Verapamil—CYP2C9—Cholecalciferol—psoriasis	0.00666	0.00882	CbGbCtD
Verapamil—CYP2C8—Hydrocortisone—psoriasis	0.00665	0.0088	CbGbCtD
Verapamil—CYP3A5—Cyclosporine—psoriasis	0.00653	0.00864	CbGbCtD
Verapamil—CYP2C8—Cyclosporine—psoriasis	0.00628	0.00831	CbGbCtD
Verapamil—ABCG2—Methotrexate—psoriasis	0.00623	0.00826	CbGbCtD
Verapamil—CYP2D6—Cholecalciferol—psoriasis	0.00609	0.00807	CbGbCtD
Verapamil—CYP3A4—Methoxsalen—psoriasis	0.00585	0.00774	CbGbCtD
Verapamil—CYP3A7-CYP3A51P—Dexamethasone—psoriasis	0.00573	0.00759	CbGbCtD
Verapamil—CYP3A7—Dexamethasone—psoriasis	0.00573	0.00759	CbGbCtD
Verapamil—ABCB1—Mycophenolate mofetil—psoriasis	0.00561	0.00742	CbGbCtD
Verapamil—CYP2C19—Prednisone—psoriasis	0.00555	0.00736	CbGbCtD
Verapamil—CYP2B6—Dexamethasone—psoriasis	0.00546	0.00723	CbGbCtD
Verapamil—CYP2C19—Cyclosporine—psoriasis	0.00527	0.00697	CbGbCtD
Verapamil—ABCB1—Betamethasone—psoriasis	0.00481	0.00637	CbGbCtD
Verapamil—ABCB1—Prednisolone—psoriasis	0.00475	0.00628	CbGbCtD
Verapamil—ABCB1—Hydrocortisone—psoriasis	0.0045	0.00596	CbGbCtD
Verapamil—ABCB1—Prednisone—psoriasis	0.00448	0.00594	CbGbCtD
Verapamil—CYP2C9—Cyclosporine—psoriasis	0.00438	0.0058	CbGbCtD
Verapamil—CYP3A5—Dexamethasone—psoriasis	0.0043	0.00569	CbGbCtD
Verapamil—ABCB1—Cyclosporine—psoriasis	0.00425	0.00563	CbGbCtD
Verapamil—CYP2C8—Dexamethasone—psoriasis	0.00413	0.00547	CbGbCtD
Verapamil—CYP2D6—Cyclosporine—psoriasis	0.004	0.0053	CbGbCtD
Verapamil—CYP3A4—Cholecalciferol—psoriasis	0.00387	0.00513	CbGbCtD
Verapamil—CYP2C19—Dexamethasone—psoriasis	0.00347	0.00459	CbGbCtD
Verapamil—CYP3A4—Mycophenolate mofetil—psoriasis	0.00336	0.00445	CbGbCtD
Verapamil—CYP3A4—Triamcinolone—psoriasis	0.00336	0.00445	CbGbCtD
Verapamil—CYP2C9—Dexamethasone—psoriasis	0.00288	0.00382	CbGbCtD
Verapamil—CYP3A4—Betamethasone—psoriasis	0.00288	0.00382	CbGbCtD
Verapamil—CYP3A4—Prednisolone—psoriasis	0.00284	0.00377	CbGbCtD
Verapamil—ABCB1—Dexamethasone—psoriasis	0.0028	0.00371	CbGbCtD
Verapamil—CYP3A4—Hydrocortisone—psoriasis	0.0027	0.00357	CbGbCtD
Verapamil—CYP3A4—Prednisone—psoriasis	0.00268	0.00356	CbGbCtD
Verapamil—CYP2D6—Dexamethasone—psoriasis	0.00264	0.00349	CbGbCtD
Verapamil—CYP3A4—Cyclosporine—psoriasis	0.00255	0.00337	CbGbCtD
Verapamil—ABCB1—Methotrexate—psoriasis	0.00225	0.00298	CbGbCtD
Verapamil—CYP3A4—Dexamethasone—psoriasis	0.00168	0.00222	CbGbCtD
Verapamil—CACNB4—tendon—psoriasis	0.00078	0.0555	CbGeAlD
Verapamil—CACNA1S—tendon—psoriasis	0.000668	0.0475	CbGeAlD
Verapamil—CACNB1—tendon—psoriasis	0.000623	0.0443	CbGeAlD
Verapamil—CACNB3—tendon—psoriasis	0.000597	0.0425	CbGeAlD
Verapamil—CACNB2—tendon—psoriasis	0.000401	0.0286	CbGeAlD
Verapamil—KCNJ11—tendon—psoriasis	0.000381	0.0271	CbGeAlD
Verapamil—ABCC10—tendon—psoriasis	0.000293	0.0209	CbGeAlD
Verapamil—SLC22A4—tendon—psoriasis	0.000276	0.0196	CbGeAlD
Verapamil—ABCC4—tendon—psoriasis	0.000243	0.0173	CbGeAlD
Verapamil—SLC22A5—skin of body—psoriasis	0.00024	0.017	CbGeAlD
Verapamil—ABCC2—tendon—psoriasis	0.000235	0.0167	CbGeAlD
Verapamil—CYP2B6—skin of body—psoriasis	0.000208	0.0148	CbGeAlD
Verapamil—ABCC1—tendon—psoriasis	0.000207	0.0148	CbGeAlD
Verapamil—SLC22A5—tendon—psoriasis	0.000182	0.013	CbGeAlD
Verapamil—Asthenia—Mycophenolic acid—psoriasis	0.000114	0.000656	CcSEcCtD
Verapamil—Hypertension—Triamcinolone—psoriasis	0.000114	0.000654	CcSEcCtD
Verapamil—Infection—Hydrocortisone—psoriasis	0.000113	0.000653	CcSEcCtD
Verapamil—Insomnia—Mycophenolate mofetil—psoriasis	0.000113	0.000652	CcSEcCtD
Verapamil—Dyspepsia—Cyclosporine—psoriasis	0.000113	0.000651	CcSEcCtD
Verapamil—Hyperhidrosis—Prednisolone—psoriasis	0.000113	0.00065	CcSEcCtD
Verapamil—Nausea—Hydroxyurea—psoriasis	0.000113	0.000648	CcSEcCtD
Verapamil—Paraesthesia—Mycophenolate mofetil—psoriasis	0.000113	0.000648	CcSEcCtD
Verapamil—Pruritus—Mycophenolic acid—psoriasis	0.000112	0.000646	CcSEcCtD
Verapamil—Shock—Hydrocortisone—psoriasis	0.000112	0.000646	CcSEcCtD
Verapamil—Myalgia—Triamcinolone—psoriasis	0.000112	0.000645	CcSEcCtD
Verapamil—Dyspnoea—Mycophenolate mofetil—psoriasis	0.000112	0.000643	CcSEcCtD
Verapamil—Tachycardia—Hydrocortisone—psoriasis	0.000111	0.000641	CcSEcCtD
Verapamil—Somnolence—Mycophenolate mofetil—psoriasis	0.000111	0.000641	CcSEcCtD
Verapamil—Drowsiness—Methotrexate—psoriasis	0.000111	0.000641	CcSEcCtD
Verapamil—Flushing—Prednisone—psoriasis	0.000111	0.000639	CcSEcCtD
Verapamil—Discomfort—Triamcinolone—psoriasis	0.000111	0.000638	CcSEcCtD
Verapamil—Fatigue—Cyclosporine—psoriasis	0.000111	0.000637	CcSEcCtD
Verapamil—Hyperhidrosis—Hydrocortisone—psoriasis	0.00011	0.000635	CcSEcCtD
Verapamil—Stevens-Johnson syndrome—Methotrexate—psoriasis	0.00011	0.000635	CcSEcCtD
Verapamil—Dyspepsia—Mycophenolate mofetil—psoriasis	0.00011	0.000635	CcSEcCtD
Verapamil—Constipation—Cyclosporine—psoriasis	0.00011	0.000632	CcSEcCtD
Verapamil—Pain—Cyclosporine—psoriasis	0.00011	0.000632	CcSEcCtD
Verapamil—Dry mouth—Triamcinolone—psoriasis	0.00011	0.000631	CcSEcCtD
Verapamil—Angioedema—Dexamethasone—psoriasis	0.000109	0.000628	CcSEcCtD
Verapamil—Angioedema—Betamethasone—psoriasis	0.000109	0.000628	CcSEcCtD
Verapamil—Diarrhoea—Mycophenolic acid—psoriasis	0.000109	0.000625	CcSEcCtD
Verapamil—Anaphylactic shock—Triamcinolone—psoriasis	0.000108	0.000619	CcSEcCtD
Verapamil—Oedema—Triamcinolone—psoriasis	0.000108	0.000619	CcSEcCtD
Verapamil—Vertigo—Betamethasone—psoriasis	0.000107	0.000618	CcSEcCtD
Verapamil—Vertigo—Dexamethasone—psoriasis	0.000107	0.000618	CcSEcCtD
Verapamil—Syncope—Betamethasone—psoriasis	0.000107	0.000617	CcSEcCtD
Verapamil—Syncope—Dexamethasone—psoriasis	0.000107	0.000617	CcSEcCtD
Verapamil—Constipation—Mycophenolate mofetil—psoriasis	0.000107	0.000617	CcSEcCtD
Verapamil—Pain—Mycophenolate mofetil—psoriasis	0.000107	0.000617	CcSEcCtD
Verapamil—Infection—Triamcinolone—psoriasis	0.000107	0.000615	CcSEcCtD
Verapamil—Sweating—Methotrexate—psoriasis	0.000107	0.000614	CcSEcCtD
Verapamil—Hypotension—Hydrocortisone—psoriasis	0.000107	0.000614	CcSEcCtD
Verapamil—Feeling abnormal—Cyclosporine—psoriasis	0.000106	0.000609	CcSEcCtD
Verapamil—Shock—Triamcinolone—psoriasis	0.000106	0.000609	CcSEcCtD
Verapamil—Insomnia—Prednisolone—psoriasis	0.000106	0.000608	CcSEcCtD
Verapamil—Alopecia—Prednisone—psoriasis	0.000106	0.000608	CcSEcCtD
Verapamil—Loss of consciousness—Betamethasone—psoriasis	0.000105	0.000604	CcSEcCtD
Verapamil—Loss of consciousness—Dexamethasone—psoriasis	0.000105	0.000604	CcSEcCtD
Verapamil—Dizziness—Mycophenolic acid—psoriasis	0.000105	0.000604	CcSEcCtD
Verapamil—Paraesthesia—Prednisolone—psoriasis	0.000105	0.000604	CcSEcCtD
Verapamil—Tachycardia—Triamcinolone—psoriasis	0.000105	0.000604	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000104	0.000599	CcSEcCtD
Verapamil—Hyperhidrosis—Triamcinolone—psoriasis	0.000104	0.000598	CcSEcCtD
Verapamil—Convulsion—Dexamethasone—psoriasis	0.000104	0.000596	CcSEcCtD
Verapamil—Convulsion—Betamethasone—psoriasis	0.000104	0.000596	CcSEcCtD
Verapamil—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000103	0.000594	CcSEcCtD
Verapamil—Insomnia—Hydrocortisone—psoriasis	0.000103	0.000594	CcSEcCtD
Verapamil—Hypertension—Betamethasone—psoriasis	0.000103	0.000594	CcSEcCtD
Verapamil—Hypertension—Dexamethasone—psoriasis	0.000103	0.000594	CcSEcCtD
Verapamil—Paraesthesia—Hydrocortisone—psoriasis	0.000103	0.00059	CcSEcCtD
Verapamil—Urticaria—Cyclosporine—psoriasis	0.000102	0.000587	CcSEcCtD
Verapamil—Myalgia—Dexamethasone—psoriasis	0.000102	0.000586	CcSEcCtD
Verapamil—Myalgia—Betamethasone—psoriasis	0.000102	0.000586	CcSEcCtD
Verapamil—Vomiting—Mycophenolic acid—psoriasis	0.000101	0.000581	CcSEcCtD
Verapamil—Discomfort—Dexamethasone—psoriasis	0.000101	0.000578	CcSEcCtD
Verapamil—Discomfort—Betamethasone—psoriasis	0.000101	0.000578	CcSEcCtD
Verapamil—Dyspepsia—Hydrocortisone—psoriasis	0.000101	0.000578	CcSEcCtD
Verapamil—Rash—Mycophenolic acid—psoriasis	0.0001	0.000576	CcSEcCtD
Verapamil—Dermatitis—Mycophenolic acid—psoriasis	0.0001	0.000576	CcSEcCtD
Verapamil—Pain—Prednisolone—psoriasis	0.0001	0.000575	CcSEcCtD
Verapamil—Hepatitis—Methotrexate—psoriasis	9.99e-05	0.000575	CcSEcCtD
Verapamil—Urticaria—Mycophenolate mofetil—psoriasis	9.96e-05	0.000573	CcSEcCtD
Verapamil—Headache—Mycophenolic acid—psoriasis	9.95e-05	0.000572	CcSEcCtD
Verapamil—Pharyngitis—Methotrexate—psoriasis	9.92e-05	0.000571	CcSEcCtD
Verapamil—Fatigue—Hydrocortisone—psoriasis	9.85e-05	0.000566	CcSEcCtD
Verapamil—Vision blurred—Prednisone—psoriasis	9.81e-05	0.000564	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Triamcinolone—psoriasis	9.8e-05	0.000564	CcSEcCtD
Verapamil—Pain—Hydrocortisone—psoriasis	9.77e-05	0.000562	CcSEcCtD
Verapamil—Oedema—Dexamethasone—psoriasis	9.76e-05	0.000561	CcSEcCtD
Verapamil—Anaphylactic shock—Dexamethasone—psoriasis	9.76e-05	0.000561	CcSEcCtD
Verapamil—Anaphylactic shock—Betamethasone—psoriasis	9.76e-05	0.000561	CcSEcCtD
Verapamil—Oedema—Betamethasone—psoriasis	9.76e-05	0.000561	CcSEcCtD
Verapamil—Insomnia—Triamcinolone—psoriasis	9.73e-05	0.000559	CcSEcCtD
Verapamil—Infection—Dexamethasone—psoriasis	9.69e-05	0.000558	CcSEcCtD
Verapamil—Infection—Betamethasone—psoriasis	9.69e-05	0.000558	CcSEcCtD
Verapamil—Paraesthesia—Triamcinolone—psoriasis	9.65e-05	0.000555	CcSEcCtD
Verapamil—Feeling abnormal—Prednisolone—psoriasis	9.64e-05	0.000554	CcSEcCtD
Verapamil—Visual impairment—Methotrexate—psoriasis	9.63e-05	0.000554	CcSEcCtD
Verapamil—Shock—Dexamethasone—psoriasis	9.6e-05	0.000552	CcSEcCtD
Verapamil—Shock—Betamethasone—psoriasis	9.6e-05	0.000552	CcSEcCtD
Verapamil—Dyspnoea—Triamcinolone—psoriasis	9.59e-05	0.000551	CcSEcCtD
Verapamil—Agitation—Prednisone—psoriasis	9.57e-05	0.00055	CcSEcCtD
Verapamil—Tachycardia—Dexamethasone—psoriasis	9.52e-05	0.000548	CcSEcCtD
Verapamil—Tachycardia—Betamethasone—psoriasis	9.52e-05	0.000548	CcSEcCtD
Verapamil—Angioedema—Prednisone—psoriasis	9.51e-05	0.000547	CcSEcCtD
Verapamil—Hypersensitivity—Cyclosporine—psoriasis	9.47e-05	0.000545	CcSEcCtD
Verapamil—Dyspepsia—Triamcinolone—psoriasis	9.46e-05	0.000545	CcSEcCtD
Verapamil—Erythema multiforme—Methotrexate—psoriasis	9.45e-05	0.000544	CcSEcCtD
Verapamil—Nausea—Mycophenolic acid—psoriasis	9.43e-05	0.000543	CcSEcCtD
Verapamil—Hyperhidrosis—Betamethasone—psoriasis	9.43e-05	0.000543	CcSEcCtD
Verapamil—Hyperhidrosis—Dexamethasone—psoriasis	9.43e-05	0.000543	CcSEcCtD
Verapamil—Feeling abnormal—Hydrocortisone—psoriasis	9.41e-05	0.000541	CcSEcCtD
Verapamil—Vertigo—Prednisone—psoriasis	9.35e-05	0.000538	CcSEcCtD
Verapamil—Syncope—Prednisone—psoriasis	9.34e-05	0.000537	CcSEcCtD
Verapamil—Tinnitus—Methotrexate—psoriasis	9.32e-05	0.000536	CcSEcCtD
Verapamil—Urticaria—Prednisolone—psoriasis	9.29e-05	0.000534	CcSEcCtD
Verapamil—Fatigue—Triamcinolone—psoriasis	9.27e-05	0.000533	CcSEcCtD
Verapamil—Hypersensitivity—Mycophenolate mofetil—psoriasis	9.23e-05	0.000531	CcSEcCtD
Verapamil—Asthenia—Cyclosporine—psoriasis	9.22e-05	0.00053	CcSEcCtD
Verapamil—Pain—Triamcinolone—psoriasis	9.19e-05	0.000529	CcSEcCtD
Verapamil—Loss of consciousness—Prednisone—psoriasis	9.15e-05	0.000526	CcSEcCtD
Verapamil—Hypotension—Dexamethasone—psoriasis	9.12e-05	0.000524	CcSEcCtD
Verapamil—Hypotension—Betamethasone—psoriasis	9.12e-05	0.000524	CcSEcCtD
Verapamil—Pruritus—Cyclosporine—psoriasis	9.09e-05	0.000523	CcSEcCtD
Verapamil—Urticaria—Hydrocortisone—psoriasis	9.07e-05	0.000522	CcSEcCtD
Verapamil—Convulsion—Prednisone—psoriasis	9.02e-05	0.000519	CcSEcCtD
Verapamil—Asthenia—Mycophenolate mofetil—psoriasis	8.99e-05	0.000517	CcSEcCtD
Verapamil—Hypertension—Prednisone—psoriasis	8.99e-05	0.000517	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Betamethasone—psoriasis	8.89e-05	0.000511	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Dexamethasone—psoriasis	8.89e-05	0.000511	CcSEcCtD
Verapamil—Pruritus—Mycophenolate mofetil—psoriasis	8.87e-05	0.00051	CcSEcCtD
Verapamil—Arthralgia—Prednisone—psoriasis	8.86e-05	0.00051	CcSEcCtD
Verapamil—Myalgia—Prednisone—psoriasis	8.86e-05	0.00051	CcSEcCtD
Verapamil—Feeling abnormal—Triamcinolone—psoriasis	8.86e-05	0.00051	CcSEcCtD
Verapamil—Alopecia—Methotrexate—psoriasis	8.83e-05	0.000508	CcSEcCtD
Verapamil—Insomnia—Dexamethasone—psoriasis	8.82e-05	0.000508	CcSEcCtD
Verapamil—Insomnia—Betamethasone—psoriasis	8.82e-05	0.000508	CcSEcCtD
Verapamil—Diarrhoea—Cyclosporine—psoriasis	8.79e-05	0.000506	CcSEcCtD
Verapamil—Paraesthesia—Betamethasone—psoriasis	8.76e-05	0.000504	CcSEcCtD
Verapamil—Paraesthesia—Dexamethasone—psoriasis	8.76e-05	0.000504	CcSEcCtD
Verapamil—Discomfort—Prednisone—psoriasis	8.76e-05	0.000504	CcSEcCtD
Verapamil—Hypersensitivity—Prednisolone—psoriasis	8.61e-05	0.000496	CcSEcCtD
Verapamil—Dyspepsia—Betamethasone—psoriasis	8.59e-05	0.000494	CcSEcCtD
Verapamil—Dyspepsia—Dexamethasone—psoriasis	8.59e-05	0.000494	CcSEcCtD
Verapamil—Diarrhoea—Mycophenolate mofetil—psoriasis	8.58e-05	0.000493	CcSEcCtD
Verapamil—Urticaria—Triamcinolone—psoriasis	8.54e-05	0.000491	CcSEcCtD
Verapamil—Dizziness—Cyclosporine—psoriasis	8.5e-05	0.000489	CcSEcCtD
Verapamil—Oedema—Prednisone—psoriasis	8.5e-05	0.000489	CcSEcCtD
Verapamil—Anaphylactic shock—Prednisone—psoriasis	8.5e-05	0.000489	CcSEcCtD
Verapamil—Infection—Prednisone—psoriasis	8.44e-05	0.000486	CcSEcCtD
Verapamil—Hypersensitivity—Hydrocortisone—psoriasis	8.41e-05	0.000484	CcSEcCtD
Verapamil—Fatigue—Betamethasone—psoriasis	8.41e-05	0.000484	CcSEcCtD
Verapamil—Fatigue—Dexamethasone—psoriasis	8.41e-05	0.000484	CcSEcCtD
Verapamil—Shock—Prednisone—psoriasis	8.36e-05	0.000481	CcSEcCtD
Verapamil—Pain—Dexamethasone—psoriasis	8.34e-05	0.00048	CcSEcCtD
Verapamil—Pain—Betamethasone—psoriasis	8.34e-05	0.00048	CcSEcCtD
Verapamil—Tachycardia—Prednisone—psoriasis	8.29e-05	0.000477	CcSEcCtD
Verapamil—Dizziness—Mycophenolate mofetil—psoriasis	8.29e-05	0.000477	CcSEcCtD
Verapamil—Hyperhidrosis—Prednisone—psoriasis	8.21e-05	0.000473	CcSEcCtD
Verapamil—Vision blurred—Methotrexate—psoriasis	8.2e-05	0.000472	CcSEcCtD
Verapamil—Asthenia—Hydrocortisone—psoriasis	8.19e-05	0.000471	CcSEcCtD
Verapamil—Vomiting—Cyclosporine—psoriasis	8.17e-05	0.00047	CcSEcCtD
Verapamil—Rash—Cyclosporine—psoriasis	8.1e-05	0.000466	CcSEcCtD
Verapamil—Dermatitis—Cyclosporine—psoriasis	8.09e-05	0.000466	CcSEcCtD
Verapamil—Pruritus—Hydrocortisone—psoriasis	8.08e-05	0.000465	CcSEcCtD
Verapamil—Headache—Cyclosporine—psoriasis	8.05e-05	0.000463	CcSEcCtD
Verapamil—Feeling abnormal—Dexamethasone—psoriasis	8.04e-05	0.000463	CcSEcCtD
Verapamil—Feeling abnormal—Betamethasone—psoriasis	8.04e-05	0.000463	CcSEcCtD
Verapamil—Vomiting—Mycophenolate mofetil—psoriasis	7.97e-05	0.000458	CcSEcCtD
Verapamil—Hypersensitivity—Triamcinolone—psoriasis	7.92e-05	0.000456	CcSEcCtD
Verapamil—Rash—Mycophenolate mofetil—psoriasis	7.9e-05	0.000455	CcSEcCtD
Verapamil—Dermatitis—Mycophenolate mofetil—psoriasis	7.9e-05	0.000454	CcSEcCtD
Verapamil—Headache—Mycophenolate mofetil—psoriasis	7.85e-05	0.000452	CcSEcCtD
Verapamil—Vertigo—Methotrexate—psoriasis	7.82e-05	0.00045	CcSEcCtD
Verapamil—Diarrhoea—Hydrocortisone—psoriasis	7.81e-05	0.000449	CcSEcCtD
Verapamil—Urticaria—Betamethasone—psoriasis	7.75e-05	0.000446	CcSEcCtD
Verapamil—Urticaria—Dexamethasone—psoriasis	7.75e-05	0.000446	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Prednisone—psoriasis	7.74e-05	0.000445	CcSEcCtD
Verapamil—Dizziness—Prednisolone—psoriasis	7.73e-05	0.000445	CcSEcCtD
Verapamil—Asthenia—Triamcinolone—psoriasis	7.71e-05	0.000444	CcSEcCtD
Verapamil—Insomnia—Prednisone—psoriasis	7.68e-05	0.000442	CcSEcCtD
Verapamil—Nausea—Cyclosporine—psoriasis	7.63e-05	0.000439	CcSEcCtD
Verapamil—Paraesthesia—Prednisone—psoriasis	7.63e-05	0.000439	CcSEcCtD
Verapamil—Pruritus—Triamcinolone—psoriasis	7.61e-05	0.000438	CcSEcCtD
Verapamil—Dizziness—Hydrocortisone—psoriasis	7.55e-05	0.000434	CcSEcCtD
Verapamil—Convulsion—Methotrexate—psoriasis	7.54e-05	0.000434	CcSEcCtD
Verapamil—Dyspepsia—Prednisone—psoriasis	7.48e-05	0.00043	CcSEcCtD
Verapamil—Nausea—Mycophenolate mofetil—psoriasis	7.45e-05	0.000428	CcSEcCtD
Verapamil—Myalgia—Methotrexate—psoriasis	7.41e-05	0.000426	CcSEcCtD
Verapamil—Chest pain—Methotrexate—psoriasis	7.41e-05	0.000426	CcSEcCtD
Verapamil—Arthralgia—Methotrexate—psoriasis	7.41e-05	0.000426	CcSEcCtD
Verapamil—Rash—Prednisolone—psoriasis	7.37e-05	0.000424	CcSEcCtD
Verapamil—Dermatitis—Prednisolone—psoriasis	7.37e-05	0.000424	CcSEcCtD
Verapamil—Fatigue—Prednisone—psoriasis	7.33e-05	0.000421	CcSEcCtD
Verapamil—Headache—Prednisolone—psoriasis	7.32e-05	0.000421	CcSEcCtD
Verapamil—Discomfort—Methotrexate—psoriasis	7.32e-05	0.000421	CcSEcCtD
Verapamil—Constipation—Prednisone—psoriasis	7.27e-05	0.000418	CcSEcCtD
Verapamil—Vomiting—Hydrocortisone—psoriasis	7.26e-05	0.000418	CcSEcCtD
Verapamil—Rash—Hydrocortisone—psoriasis	7.2e-05	0.000414	CcSEcCtD
Verapamil—Dermatitis—Hydrocortisone—psoriasis	7.19e-05	0.000414	CcSEcCtD
Verapamil—Confusional state—Methotrexate—psoriasis	7.16e-05	0.000412	CcSEcCtD
Verapamil—Headache—Hydrocortisone—psoriasis	7.15e-05	0.000412	CcSEcCtD
Verapamil—Dizziness—Triamcinolone—psoriasis	7.11e-05	0.000409	CcSEcCtD
Verapamil—Anaphylactic shock—Methotrexate—psoriasis	7.1e-05	0.000409	CcSEcCtD
Verapamil—Infection—Methotrexate—psoriasis	7.05e-05	0.000406	CcSEcCtD
Verapamil—Feeling abnormal—Prednisone—psoriasis	7e-05	0.000403	CcSEcCtD
Verapamil—Asthenia—Dexamethasone—psoriasis	7e-05	0.000403	CcSEcCtD
Verapamil—Asthenia—Betamethasone—psoriasis	7e-05	0.000403	CcSEcCtD
Verapamil—Nausea—Prednisolone—psoriasis	6.95e-05	0.0004	CcSEcCtD
Verapamil—Pruritus—Betamethasone—psoriasis	6.9e-05	0.000397	CcSEcCtD
Verapamil—Pruritus—Dexamethasone—psoriasis	6.9e-05	0.000397	CcSEcCtD
Verapamil—Hyperhidrosis—Methotrexate—psoriasis	6.86e-05	0.000395	CcSEcCtD
Verapamil—Vomiting—Triamcinolone—psoriasis	6.84e-05	0.000393	CcSEcCtD
Verapamil—Nausea—Hydrocortisone—psoriasis	6.78e-05	0.00039	CcSEcCtD
Verapamil—Rash—Triamcinolone—psoriasis	6.78e-05	0.00039	CcSEcCtD
Verapamil—Dermatitis—Triamcinolone—psoriasis	6.77e-05	0.00039	CcSEcCtD
Verapamil—Urticaria—Prednisone—psoriasis	6.75e-05	0.000388	CcSEcCtD
Verapamil—Headache—Triamcinolone—psoriasis	6.74e-05	0.000388	CcSEcCtD
Verapamil—Diarrhoea—Betamethasone—psoriasis	6.68e-05	0.000384	CcSEcCtD
Verapamil—Diarrhoea—Dexamethasone—psoriasis	6.68e-05	0.000384	CcSEcCtD
Verapamil—Hypotension—Methotrexate—psoriasis	6.64e-05	0.000382	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Methotrexate—psoriasis	6.47e-05	0.000372	CcSEcCtD
Verapamil—Dizziness—Betamethasone—psoriasis	6.45e-05	0.000371	CcSEcCtD
Verapamil—Dizziness—Dexamethasone—psoriasis	6.45e-05	0.000371	CcSEcCtD
Verapamil—Insomnia—Methotrexate—psoriasis	6.42e-05	0.000369	CcSEcCtD
Verapamil—Nausea—Triamcinolone—psoriasis	6.39e-05	0.000367	CcSEcCtD
Verapamil—Paraesthesia—Methotrexate—psoriasis	6.38e-05	0.000367	CcSEcCtD
Verapamil—Dyspnoea—Methotrexate—psoriasis	6.33e-05	0.000364	CcSEcCtD
Verapamil—Somnolence—Methotrexate—psoriasis	6.31e-05	0.000363	CcSEcCtD
Verapamil—Hypersensitivity—Prednisone—psoriasis	6.26e-05	0.00036	CcSEcCtD
Verapamil—Dyspepsia—Methotrexate—psoriasis	6.25e-05	0.00036	CcSEcCtD
Verapamil—Vomiting—Betamethasone—psoriasis	6.2e-05	0.000357	CcSEcCtD
Verapamil—Vomiting—Dexamethasone—psoriasis	6.2e-05	0.000357	CcSEcCtD
Verapamil—Rash—Betamethasone—psoriasis	6.15e-05	0.000354	CcSEcCtD
Verapamil—Rash—Dexamethasone—psoriasis	6.15e-05	0.000354	CcSEcCtD
Verapamil—Dermatitis—Betamethasone—psoriasis	6.15e-05	0.000354	CcSEcCtD
Verapamil—Dermatitis—Dexamethasone—psoriasis	6.15e-05	0.000354	CcSEcCtD
Verapamil—Fatigue—Methotrexate—psoriasis	6.12e-05	0.000352	CcSEcCtD
Verapamil—Headache—Dexamethasone—psoriasis	6.11e-05	0.000352	CcSEcCtD
Verapamil—Headache—Betamethasone—psoriasis	6.11e-05	0.000352	CcSEcCtD
Verapamil—Asthenia—Prednisone—psoriasis	6.1e-05	0.000351	CcSEcCtD
Verapamil—Pain—Methotrexate—psoriasis	6.07e-05	0.000349	CcSEcCtD
Verapamil—Pruritus—Prednisone—psoriasis	6.01e-05	0.000346	CcSEcCtD
Verapamil—Feeling abnormal—Methotrexate—psoriasis	5.85e-05	0.000337	CcSEcCtD
Verapamil—Diarrhoea—Prednisone—psoriasis	5.81e-05	0.000334	CcSEcCtD
Verapamil—Nausea—Dexamethasone—psoriasis	5.8e-05	0.000333	CcSEcCtD
Verapamil—Nausea—Betamethasone—psoriasis	5.8e-05	0.000333	CcSEcCtD
Verapamil—Urticaria—Methotrexate—psoriasis	5.64e-05	0.000325	CcSEcCtD
Verapamil—Dizziness—Prednisone—psoriasis	5.62e-05	0.000323	CcSEcCtD
Verapamil—Vomiting—Prednisone—psoriasis	5.4e-05	0.000311	CcSEcCtD
Verapamil—Rash—Prednisone—psoriasis	5.36e-05	0.000308	CcSEcCtD
Verapamil—Dermatitis—Prednisone—psoriasis	5.35e-05	0.000308	CcSEcCtD
Verapamil—Headache—Prednisone—psoriasis	5.32e-05	0.000306	CcSEcCtD
Verapamil—Hypersensitivity—Methotrexate—psoriasis	5.23e-05	0.000301	CcSEcCtD
Verapamil—Asthenia—Methotrexate—psoriasis	5.09e-05	0.000293	CcSEcCtD
Verapamil—Nausea—Prednisone—psoriasis	5.05e-05	0.00029	CcSEcCtD
Verapamil—Pruritus—Methotrexate—psoriasis	5.02e-05	0.000289	CcSEcCtD
Verapamil—Diarrhoea—Methotrexate—psoriasis	4.86e-05	0.00028	CcSEcCtD
Verapamil—Dizziness—Methotrexate—psoriasis	4.7e-05	0.00027	CcSEcCtD
Verapamil—Vomiting—Methotrexate—psoriasis	4.51e-05	0.00026	CcSEcCtD
Verapamil—Rash—Methotrexate—psoriasis	4.48e-05	0.000258	CcSEcCtD
Verapamil—Dermatitis—Methotrexate—psoriasis	4.47e-05	0.000257	CcSEcCtD
Verapamil—Headache—Methotrexate—psoriasis	4.45e-05	0.000256	CcSEcCtD
Verapamil—Nausea—Methotrexate—psoriasis	4.22e-05	0.000243	CcSEcCtD
Verapamil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	3.28e-05	0.000574	CbGpPWpGaD
Verapamil—ABCG2—Transmembrane transport of small molecules—CARM1—psoriasis	3.27e-05	0.000573	CbGpPWpGaD
Verapamil—SCN5A—Axon guidance—TYK2—psoriasis	3.22e-05	0.000564	CbGpPWpGaD
Verapamil—CACNA1A—Metabolism—CAT—psoriasis	3.19e-05	0.000559	CbGpPWpGaD
Verapamil—CACNA1I—Developmental Biology—TNF—psoriasis	3.19e-05	0.000559	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—TYK2—psoriasis	3.19e-05	0.000559	CbGpPWpGaD
Verapamil—CACNA1C—Axon guidance—TYK2—psoriasis	3.19e-05	0.000558	CbGpPWpGaD
Verapamil—CACNB3—Developmental Biology—VEGFA—psoriasis	3.16e-05	0.000554	CbGpPWpGaD
Verapamil—SLC22A1—Transmembrane transport of small molecules—CP—psoriasis	3.16e-05	0.000554	CbGpPWpGaD
Verapamil—CACNA1S—Axon guidance—VEGFA—psoriasis	3.16e-05	0.000554	CbGpPWpGaD
Verapamil—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	3.16e-05	0.000553	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—CYP2S1—psoriasis	3.14e-05	0.00055	CbGpPWpGaD
Verapamil—CACNB3—Developmental Biology—STAT3—psoriasis	3.13e-05	0.000549	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—PPARG—psoriasis	3.12e-05	0.000546	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—CYP2S1—psoriasis	3.11e-05	0.000545	CbGpPWpGaD
Verapamil—ABCB1—Allograft Rejection—IFNG—psoriasis	3.08e-05	0.00054	CbGpPWpGaD
Verapamil—CACNB1—Developmental Biology—VEGFA—psoriasis	3.08e-05	0.000539	CbGpPWpGaD
Verapamil—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	3.08e-05	0.000539	CbGpPWpGaD
Verapamil—CACNB3—Axon guidance—IL6—psoriasis	3.07e-05	0.000537	CbGpPWpGaD
Verapamil—SLC6A4—SIDS Susceptibility Pathways—TNF—psoriasis	3.06e-05	0.000536	CbGpPWpGaD
Verapamil—CACNB1—Developmental Biology—STAT3—psoriasis	3.05e-05	0.000534	CbGpPWpGaD
Verapamil—CACNA1G—Developmental Biology—NFKB1—psoriasis	3.02e-05	0.00053	CbGpPWpGaD
Verapamil—SLC22A1—Transmembrane transport of small molecules—CARM1—psoriasis	3.02e-05	0.000529	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—LEP—psoriasis	3.01e-05	0.000528	CbGpPWpGaD
Verapamil—CACNB3—Metabolism—CAT—psoriasis	3e-05	0.000526	CbGpPWpGaD
Verapamil—CACNB1—Axon guidance—IL6—psoriasis	2.98e-05	0.000523	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—CARM1—psoriasis	2.98e-05	0.000522	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—LEP—psoriasis	2.98e-05	0.000522	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—PPARG—psoriasis	2.95e-05	0.000518	CbGpPWpGaD
Verapamil—CACNA1H—Developmental Biology—NFKB1—psoriasis	2.93e-05	0.000513	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—CYP2S1—psoriasis	2.89e-05	0.000507	CbGpPWpGaD
Verapamil—ABCB1—Allograft Rejection—CXCL8—psoriasis	2.87e-05	0.000502	CbGpPWpGaD
Verapamil—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	2.86e-05	0.000502	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—CARM1—psoriasis	2.84e-05	0.000498	CbGpPWpGaD
Verapamil—SCN5A—SIDS Susceptibility Pathways—IL6—psoriasis	2.83e-05	0.000495	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—CARM1—psoriasis	2.82e-05	0.000494	CbGpPWpGaD
Verapamil—CACNA1G—Developmental Biology—VEGFA—psoriasis	2.74e-05	0.000481	CbGpPWpGaD
Verapamil—KCNH2—SIDS Susceptibility Pathways—IL6—psoriasis	2.74e-05	0.00048	CbGpPWpGaD
Verapamil—CACNB4—Developmental Biology—IL6—psoriasis	2.74e-05	0.00048	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—TYK2—psoriasis	2.73e-05	0.000479	CbGpPWpGaD
Verapamil—CACNA1G—Developmental Biology—STAT3—psoriasis	2.72e-05	0.000476	CbGpPWpGaD
Verapamil—CACNB3—Developmental Biology—TNF—psoriasis	2.71e-05	0.000475	CbGpPWpGaD
Verapamil—CACNB2—Axon guidance—VEGFA—psoriasis	2.71e-05	0.000475	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—NDUFA5—psoriasis	2.7e-05	0.000474	CbGpPWpGaD
Verapamil—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	2.69e-05	0.000471	CbGpPWpGaD
Verapamil—CACNA1G—Axon guidance—IL6—psoriasis	2.66e-05	0.000466	CbGpPWpGaD
Verapamil—CACNA1H—Developmental Biology—VEGFA—psoriasis	2.66e-05	0.000465	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—NDUFA5—psoriasis	2.64e-05	0.000463	CbGpPWpGaD
Verapamil—CACNB1—Developmental Biology—TNF—psoriasis	2.64e-05	0.000462	CbGpPWpGaD
Verapamil—CACNA1H—Developmental Biology—STAT3—psoriasis	2.63e-05	0.000461	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—PPARG—psoriasis	2.62e-05	0.00046	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—PPARG—psoriasis	2.6e-05	0.000455	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—TYK2—psoriasis	2.59e-05	0.000453	CbGpPWpGaD
Verapamil—ABCC4—Platelet activation, signaling and aggregation—VEGFA—psoriasis	2.58e-05	0.000452	CbGpPWpGaD
Verapamil—CACNA1H—Axon guidance—IL6—psoriasis	2.57e-05	0.000451	CbGpPWpGaD
Verapamil—CACNA1I—Developmental Biology—IL6—psoriasis	2.57e-05	0.000451	CbGpPWpGaD
Verapamil—CACNA1D—Axon guidance—VEGFA—psoriasis	2.56e-05	0.000449	CbGpPWpGaD
Verapamil—ABCB11—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.49e-05	0.000436	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—NFKB1—psoriasis	2.48e-05	0.000435	CbGpPWpGaD
Verapamil—CACNA1A—Metabolism—APOE—psoriasis	2.48e-05	0.000434	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—CARM1—psoriasis	2.48e-05	0.000434	CbGpPWpGaD
Verapamil—SLC6A4—SIDS Susceptibility Pathways—IL6—psoriasis	2.47e-05	0.000432	CbGpPWpGaD
Verapamil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	2.45e-05	0.00043	CbGpPWpGaD
Verapamil—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	2.45e-05	0.00043	CbGpPWpGaD
Verapamil—ABCC3—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.38e-05	0.000418	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	2.36e-05	0.000414	CbGpPWpGaD
Verapamil—CACNA1G—Developmental Biology—TNF—psoriasis	2.35e-05	0.000412	CbGpPWpGaD
Verapamil—CACNB3—Metabolism—APOE—psoriasis	2.33e-05	0.000408	CbGpPWpGaD
Verapamil—ABCB1—Allograft Rejection—VEGFA—psoriasis	2.33e-05	0.000408	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—CARM1—psoriasis	2.32e-05	0.000406	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—CYP2S1—psoriasis	2.3e-05	0.000403	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—TYK2—psoriasis	2.3e-05	0.000403	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—NOS2—psoriasis	2.29e-05	0.000402	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—NDUFA5—psoriasis	2.29e-05	0.000401	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—CARM1—psoriasis	2.28e-05	0.0004	CbGpPWpGaD
Verapamil—SCN5A—Axon guidance—VEGFA—psoriasis	2.28e-05	0.000399	CbGpPWpGaD
Verapamil—CACNA1H—Developmental Biology—TNF—psoriasis	2.28e-05	0.000399	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—TYK2—psoriasis	2.27e-05	0.000398	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—VEGFA—psoriasis	2.25e-05	0.000395	CbGpPWpGaD
Verapamil—CACNA1C—Axon guidance—VEGFA—psoriasis	2.25e-05	0.000395	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—CYP2S1—psoriasis	2.25e-05	0.000394	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—STAT3—psoriasis	2.23e-05	0.000391	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—CARM1—psoriasis	2.22e-05	0.000389	CbGpPWpGaD
Verapamil—SLC6A4—Circadian rythm related genes—TP53—psoriasis	2.2e-05	0.000386	CbGpPWpGaD
Verapamil—CACNB3—Developmental Biology—IL6—psoriasis	2.19e-05	0.000383	CbGpPWpGaD
Verapamil—CACNA1S—Axon guidance—IL6—psoriasis	2.18e-05	0.000383	CbGpPWpGaD
Verapamil—ABCB11—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.17e-05	0.00038	CbGpPWpGaD
Verapamil—CACNA1A—Metabolism—PPARG—psoriasis	2.16e-05	0.000378	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.13e-05	0.000374	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—NFKB1—psoriasis	2.13e-05	0.000373	CbGpPWpGaD
Verapamil—CACNB1—Developmental Biology—IL6—psoriasis	2.13e-05	0.000373	CbGpPWpGaD
Verapamil—ABCC3—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.08e-05	0.000364	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.08e-05	0.000364	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—NDUFA5—psoriasis	2.04e-05	0.000358	CbGpPWpGaD
Verapamil—CACNB3—Metabolism—PPARG—psoriasis	2.03e-05	0.000356	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—NFKB1—psoriasis	2.02e-05	0.000353	CbGpPWpGaD
Verapamil—SLC6A4—Circadian rythm related genes—IL6—psoriasis	2.01e-05	0.000353	CbGpPWpGaD
Verapamil—ABCB1—Allograft Rejection—TNF—psoriasis	1.99e-05	0.00035	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—NDUFA5—psoriasis	1.99e-05	0.000349	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	1.98e-05	0.000348	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—CYP2S1—psoriasis	1.95e-05	0.000341	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—CARM1—psoriasis	1.93e-05	0.000339	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—VEGFA—psoriasis	1.93e-05	0.000339	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—TNF—psoriasis	1.93e-05	0.000339	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—STAT3—psoriasis	1.91e-05	0.000335	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.91e-05	0.000334	CbGpPWpGaD
Verapamil—CACNA1G—Developmental Biology—IL6—psoriasis	1.9e-05	0.000332	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—NDUFA5—psoriasis	1.88e-05	0.000329	CbGpPWpGaD
Verapamil—CACNB2—Axon guidance—IL6—psoriasis	1.87e-05	0.000328	CbGpPWpGaD
Verapamil—ABCC1—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.87e-05	0.000327	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—NDUFA5—psoriasis	1.86e-05	0.000326	CbGpPWpGaD
Verapamil—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	1.85e-05	0.000325	CbGpPWpGaD
Verapamil—CACNA1H—Developmental Biology—IL6—psoriasis	1.84e-05	0.000322	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—CAT—psoriasis	1.83e-05	0.000321	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—VEGFA—psoriasis	1.83e-05	0.000321	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—STAT3—psoriasis	1.81e-05	0.000318	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.81e-05	0.000317	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—NFKB1—psoriasis	1.79e-05	0.000314	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.78e-05	0.000311	CbGpPWpGaD
Verapamil—CACNA1D—Axon guidance—IL6—psoriasis	1.77e-05	0.000311	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—NFKB1—psoriasis	1.77e-05	0.00031	CbGpPWpGaD
Verapamil—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	1.77e-05	0.00031	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—CAT—psoriasis	1.75e-05	0.000306	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—CARM1—psoriasis	1.74e-05	0.000305	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—CYP2S1—psoriasis	1.74e-05	0.000304	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.74e-05	0.000304	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—CAT—psoriasis	1.74e-05	0.000304	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—CYP2S1—psoriasis	1.7e-05	0.000297	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—TNF—psoriasis	1.66e-05	0.00029	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—CARM1—psoriasis	1.65e-05	0.00029	CbGpPWpGaD
Verapamil—ABCC1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.63e-05	0.000285	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—VEGFA—psoriasis	1.63e-05	0.000285	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—STAT3—psoriasis	1.61e-05	0.000282	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—VEGFA—psoriasis	1.61e-05	0.000282	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—CYP2S1—psoriasis	1.6e-05	0.00028	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—STAT3—psoriasis	1.59e-05	0.000279	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—NDUFA5—psoriasis	1.59e-05	0.000279	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—CYP2S1—psoriasis	1.58e-05	0.000278	CbGpPWpGaD
Verapamil—SCN5A—Axon guidance—IL6—psoriasis	1.58e-05	0.000276	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—TNF—psoriasis	1.57e-05	0.000275	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—IL6—psoriasis	1.56e-05	0.000273	CbGpPWpGaD
Verapamil—CACNA1C—Axon guidance—IL6—psoriasis	1.56e-05	0.000273	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.55e-05	0.000271	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—CARM1—psoriasis	1.53e-05	0.000268	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—CAT—psoriasis	1.53e-05	0.000267	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—CARM1—psoriasis	1.52e-05	0.000266	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.48e-05	0.00026	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—CAT—psoriasis	1.43e-05	0.00025	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—APOE—psoriasis	1.42e-05	0.00025	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—CARM1—psoriasis	1.41e-05	0.000248	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—CAT—psoriasis	1.4e-05	0.000246	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—TNF—psoriasis	1.39e-05	0.000244	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—TNF—psoriasis	1.38e-05	0.000241	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—CAT—psoriasis	1.37e-05	0.000239	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—APOE—psoriasis	1.36e-05	0.000238	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CYP2S1—psoriasis	1.35e-05	0.000237	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—APOE—psoriasis	1.35e-05	0.000236	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—IL6—psoriasis	1.34e-05	0.000234	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—VEGFA—psoriasis	1.33e-05	0.000233	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.31e-05	0.00023	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—IL6—psoriasis	1.27e-05	0.000222	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.27e-05	0.000222	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—PPARG—psoriasis	1.24e-05	0.000217	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—NDUFA5—psoriasis	1.23e-05	0.000215	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—CAT—psoriasis	1.19e-05	0.000209	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—APOE—psoriasis	1.18e-05	0.000208	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—PPARG—psoriasis	1.18e-05	0.000207	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—PPARG—psoriasis	1.17e-05	0.000206	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.15e-05	0.000201	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—IL6—psoriasis	1.12e-05	0.000197	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—CARM1—psoriasis	1.12e-05	0.000197	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—IL6—psoriasis	1.11e-05	0.000195	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—APOE—psoriasis	1.11e-05	0.000194	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—CARM1—psoriasis	1.1e-05	0.000192	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—APOE—psoriasis	1.09e-05	0.000191	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—CAT—psoriasis	1.07e-05	0.000188	CbGpPWpGaD
Verapamil—ABCC1—Disease—HLA-A—psoriasis	1.06e-05	0.000186	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—APOE—psoriasis	1.06e-05	0.000186	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CYP2S1—psoriasis	1.04e-05	0.000183	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—PPARG—psoriasis	1.03e-05	0.000181	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.02e-05	0.000179	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—CAT—psoriasis	1.02e-05	0.000178	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—TP53—psoriasis	1e-05	0.000176	CbGpPWpGaD
Verapamil—ABCC1—Disease—APOE—psoriasis	9.93e-06	0.000174	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	9.84e-06	0.000173	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—PPARG—psoriasis	9.65e-06	0.000169	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—PPARG—psoriasis	9.51e-06	0.000167	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—CARM1—psoriasis	9.51e-06	0.000167	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—CAT—psoriasis	9.42e-06	0.000165	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—CAT—psoriasis	9.34e-06	0.000164	CbGpPWpGaD
Verapamil—ABCC1—Disease—NOS2—psoriasis	9.26e-06	0.000162	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—PPARG—psoriasis	9.25e-06	0.000162	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—APOE—psoriasis	9.25e-06	0.000162	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	9.11e-06	0.00016	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	8.89e-06	0.000156	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—CAT—psoriasis	8.69e-06	0.000152	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	8.68e-06	0.000152	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—CARM1—psoriasis	8.48e-06	0.000149	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—APOE—psoriasis	8.32e-06	0.000146	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	8.3e-06	0.000145	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—CARM1—psoriasis	8.28e-06	0.000145	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—PPARG—psoriasis	8.05e-06	0.000141	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	7.93e-06	0.000139	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—APOE—psoriasis	7.91e-06	0.000139	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—CARM1—psoriasis	7.8e-06	0.000137	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—CARM1—psoriasis	7.74e-06	0.000136	CbGpPWpGaD
Verapamil—ABCC1—Disease—TYK2—psoriasis	7.58e-06	0.000133	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—APOE—psoriasis	7.32e-06	0.000128	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—APOE—psoriasis	7.26e-06	0.000127	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—PPARG—psoriasis	7.25e-06	0.000127	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	7.23e-06	0.000127	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	7.09e-06	0.000124	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—CAT—psoriasis	6.91e-06	0.000121	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—PPARG—psoriasis	6.89e-06	0.000121	CbGpPWpGaD
Verapamil—ABCC1—Disease—CD4—psoriasis	6.86e-06	0.00012	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—APOE—psoriasis	6.75e-06	0.000118	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—CAT—psoriasis	6.75e-06	0.000118	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CARM1—psoriasis	6.61e-06	0.000116	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—PPARG—psoriasis	6.38e-06	0.000112	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—PPARG—psoriasis	6.32e-06	0.000111	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	6.18e-06	0.000108	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—PPARG—psoriasis	5.88e-06	0.000103	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—CAT—psoriasis	5.85e-06	0.000102	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—APOE—psoriasis	5.37e-06	9.4e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—STAT3—psoriasis	5.31e-06	9.3e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—APOE—psoriasis	5.25e-06	9.19e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—CAT—psoriasis	5.22e-06	9.15e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CARM1—psoriasis	5.1e-06	8.94e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—CAT—psoriasis	5.09e-06	8.93e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—CAT—psoriasis	4.8e-06	8.41e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—CAT—psoriasis	4.76e-06	8.34e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PPARG—psoriasis	4.67e-06	8.19e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PPARG—psoriasis	4.57e-06	8.01e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—APOE—psoriasis	4.54e-06	7.96e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CAT—psoriasis	4.07e-06	7.13e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—APOE—psoriasis	4.06e-06	7.11e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—APOE—psoriasis	3.96e-06	6.94e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PPARG—psoriasis	3.96e-06	6.93e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—APOE—psoriasis	3.73e-06	6.54e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—IL6—psoriasis	3.71e-06	6.5e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—APOE—psoriasis	3.7e-06	6.48e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PPARG—psoriasis	3.53e-06	6.19e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PPARG—psoriasis	3.45e-06	6.04e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PPARG—psoriasis	3.25e-06	5.69e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PPARG—psoriasis	3.22e-06	5.64e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—APOE—psoriasis	3.16e-06	5.54e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CAT—psoriasis	3.14e-06	5.5e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PPARG—psoriasis	2.75e-06	4.82e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—APOE—psoriasis	2.44e-06	4.27e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PPARG—psoriasis	2.12e-06	3.72e-05	CbGpPWpGaD
